In view of the burgeoning evidence that FA/BRCA pathways regulated repair of DNA interstrand crosslinks through HR, it seemed that the FA defects contributed to the synthetic lethality in cancers treated with interstrand crosslink–inducing drugs (28, 29, 42, 43). The gene discussed is FANCA; the disease is cancer.